The sixteen chapters of Advances in Ovarian Cancer Management present a concise, timely and comprehensive overview on the current status of the etiology, diagnosis and treatment of women with epithelial ovarian cancer. The book introduces the incessant menstruation hypothesis, which may allow physicians to better understand and explain to patients why many serous ovarian cancers may actually be originating from the fimbriated end of the fallopian tube and why endometrioid and clear cell cancers may arise in association with endometriosis. Subsequent chapters discuss diagnostic evaluation prior to the patient undergoing treatment and the surgical and chemotherapeutic management of the disease. There are overviews of new approaches such as anti-angiogenesis therapy, PARP inhibitors, immunotherapy and emerging target therapies. Discussions of alternative treatment strategies, such as neoadjuvant chemotherapy followed by surgical cytoreduction and adjuvant chemotherapy are included, together with the management of recurrent ovarian cancer, both from a surgical perspective and from a perspective of chemotherapeutic agents. Advances in Ovarian Cancer Management concludes with a chapter on palliative care, a critical part of the overall management of women with this devastating disease. The final chapter provides contemporary guidelines for the initial management of ovarian cancer as well as for recurrent disease.